Drug
Lsp 5415
Lsp 5415: highest development phase Phase 2, developed by Lupin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| LSP-5415 NCT05360550 | Phase 2 | Pregnancy Prevention |
| LSP-5415 (etonogestrel/ethinyl estradiol vaginal ring) NCT05360576 | Phase 2 | Pregnancy Prevention |
Latest
No recent events.
Follow Lsp 5415 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.